Abstract:The NOX family proteins, as core components of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, regulate the production of reactive oxygen species (ROS) to mediate fundamental cellular physiological processes and are critically implicated in the pathogenesis of various human diseases. Within the inner ear, ROS serve as pivotal signaling molecules involved in modulating essential physiological functions such as metabolic activities and signal transduction in auditory cells. However, dysregulated ROS generation triggers cascading oxidative stress responses, leading to progressive structural and functional damage in cochlear cells. Studies demonstrate that such oxidative stress mechanisms constitute a common pathological basis for multiple forms of hearing loss, including noise-induced hearing loss, age-related hearing loss, and ototoxic drug-induced hearing loss. As primary intracellular sources of ROS, NOX family proteins play crucial roles in auditory system development and functional maintenance by mediating oxidative stress pathways. This mechanistic involvement highlights NOX family proteins as promising therapeutic targets for hearing loss intervention. This review systematically elucidates the functional roles and molecular mechanisms of NOX family proteins in the auditory system, establishing a foundation for comprehensively deciphering their pathophysiological contributions to hearing impairment. Targeting NOX family proteins holds significant potential for developing novel therapeutic agents and intervention strategies to ameliorate auditory dysfunction in clinical settings.